Cantoni Therapeutics
The company is focused on advancing its NNMT inhibitors through further research and development, with the goal of offering new therapies for metabolic syndrome and related conditions.
Cantoni Therapeutics has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Leiden, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Leiden, Netherlandscantonitx.nl ↗
Total raised
€0
€0
Funding rounds
1
Investors
3
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearCantoni Therapeutics — funding by year — interactive chart.
Data table
| Cantoni Therapeutics — funding by year | |
|---|---|
| 2025 | €0 |
Signals
Medium confidenceRaise-next likelihood42
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-18 | Other | — | angel investor,Brabantse Ontwikkelings Maatschappij (BOM),Libertatis Ergo Holding BV (LEH) | View deal → |
Investors
3Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData